Supertramp thanks for quoting me but you are not complete right IMO. The ASX does value certain biotech’s highly.
Take for example CSL. Current price $155. Market cap circa $50 billion. For people lucky to have got this stock at the float price in the early 90’s circa $2. Taking into account the 3 way split the stock price is actually over $450. Not bad from $2 float!!!
The difference is CSL is a bemoath with huge free cash flows, profits and global repute. The Aussie market values profit and cash flow in biotech’s.
The US market is larger and more willing to put a higher value on specs. So, yes Imugene would have probably been valued higher in a US listed market.
- Forums
- ASX - By Stock
- Told you so!! IMU heading to $200m Mkt Cap
Supertramp thanks for quoting me but you are not complete right...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M |
Open | High | Low | Value | Volume |
5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1082545 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 603058 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 341818 | 0.055 |
9 | 509187 | 0.054 |
14 | 1776123 | 0.053 |
22 | 1646348 | 0.052 |
16 | 4794350 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 603058 | 6 |
0.058 | 1006279 | 6 |
0.059 | 21714 | 1 |
0.060 | 1512398 | 12 |
0.061 | 1091000 | 7 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |